Predicting Competitive Effects from Prescription Drug Mergers: How Standard Economic Analysis Can Go Wrong.
- Published in:
- Antitrust Bulletin, 2014, v. 59, n. 3, p. 593, doi. 10.1177/0003603X1405900309
- By:
- Publication type:
- Article
Works matching DE "LUNDBECK Inc."
Results: 11
1
2
Nonprice Competition in “Substitute” Drugs: The FTC's Blind Spot.
- Published in:
- Antitrust Bulletin, 2014, v. 59, n. 3, p. 579, doi. 10.1177/0003603X1405900308
- By:
- Publication type:
- Article
3
FTC v. Lundbeck: Is Anything in Antitrust Obvious, Like, Ever?
- Published in:
- Antitrust Bulletin, 2014, v. 59, n. 3, p. 557, doi. 10.1177/0003603X1405900307
- By:
- Publication type:
- Article
4
Sertindole.
- Published in:
- Australian Prescriber, 2011, v. 34, n. 3, p. 90
- Publication type:
- Article
5
Patients with depression spends 94% of their time with cognitive symptoms - Farid Aslam Minhas.
- Published in:
- 2015
- Publication type:
- Proceeding
6
Lundbeck, Slovak Telekom, Google Shopping and Aspen Commitments: A Survey of Developments at the Intersection Between Competition Law and IP Law in the Past Year.
- Published in:
- Journal of European Competition Law & Practice, 2022, v. 13, n. 7, p. 516, doi. 10.1093/jeclap/lpac054
- By:
- Publication type:
- Article
7
By Object or Effect Restrictions—Reverse Payment Settlement Agreements in light of Lundbeck, Servier, and Generics.
- Published in:
- Journal of European Competition Law & Practice, 2021, v. 12, n. 4, p. 273, doi. 10.1093/jeclap/lpaa089
- By:
- Publication type:
- Article
8
LUCK AND THE LAW.
- Published in:
- TCE: The Chemical Engineer, 2009, n. 822/823, p. 20
- By:
- Publication type:
- Article
9
Lundbeck Moves PACAP-Targeting Antibody into Multinational Phase 2b Clinical Trial.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
10
Drug approved to treat infantile spasms.
- Published in:
- American Journal of Health-System Pharmacy, 2009, v. 66, n. 19, p. 1682, doi. 10.2146/news090077
- By:
- Publication type:
- Article
11
A FISTFUL OF EUROS: EU COMPETITION POLICY AND REVERSE PAYMENTS IN THE PHARMACEUTICAL INDUSTRY.
- Published in:
- European Competition Journal, 2014, v. 10, n. 3, p. 499, doi. 10.5235/17441056.10.3.499
- By:
- Publication type:
- Article